NonprofitsNational Tuberous Sclerosis Association Inc

Disease & Medical Research

National Tuberous Sclerosis Association Inc

SILVER SPRING, MD

Total revenue

$10.0M

Total expenses

$8.7M

Net assets

$15.4M

Grants received

$7.6M

119 grants

EIN

953018799

Tax year

2024

Mission

To improve quality of life for everyone affected by tuberous sclerosis complex by catalyzing new treatments, driving research toward a cure and expanding access to lifelong support.

Programs

3 programs

Support services. See schedule o for full program description.

Expenses: $1.0M

Public health. See schedule o for full program description.

Expenses: $478K

Government relations efforts focus on increasing federal and state appropriations for tsc research, raising awareness, and collaborating with government partners to drive tsc research forward and improve clinical care and treatment options for individuals with tsc. On the state level, the tsc alliance advocated for state funding for tsc centers in alabama, missouri, and maryland, resulting in at least $1.275 million in state appropriations. The 2024 march on capitol hill was held february 28 with congressional meetings taking place through mid-march. More than 130 people participated in over 367 in-person and virtual meetings. Our house dear colleague letter for fy25 was co-sponsored by representatives fitzpatrick (r-pa) and raskin (d-md) and closed with 185 signers. The senate dear colleague letter was co-sponsored by senators cramer (r-nd) and heinrich (d-nm) and closed with 41 signers.total funding for the tscrp has been $121 million since 2002, including a $8 million appropriation for fy24. Research performed through this program has recently led to additional clinical trials including determining if imatinib, a drug fda-approved for cancer, can safely improve levels of vegf-d, a biomarker of lymphangioleiomyomatosis (lam), a life-threatening lung manifestation of tsc, funded in fy2013; two tscrp awards in fy2012 and fy2015 that enabled generation of a potential approach for gene therapy of tsc, which has shown promising results in a mouse model of tsc tumors in the brain; a multi-site clinical trial testing the efficacy of an experimental topical rapamycin cream to treat the disfiguring facial tumors, called facial angiofibromas, caused by tsc funded in fy2010 that led the third fda-approved drug to treat tsc in april 2022; and a clinical research network that was created to test potential new therapies, to validate biomarkers, and to learn the natural history of leading to a clinical trial funded in fy2012. Data obtained from an fy2010 tscrp clinical research award to define early autism predictors in tsc and an fy2014 tscrp award for a pilot clinical trial is being tested in a large, nih-funded clinical trial looking at the effectiveness of a behavioral intervention strategy, jasper, to improve outcomes in children with autism. The tscrp has also funded research to develop animal models of tsc that have seizures, enabling a better understanding of the etiology of tsc. Based on data from tscrp-funded animal models of tsc that have seizures and share pathology related to that of traumatic brain injury, an industry-sponsored clinical trial demonstrated the effectiveness the mtor inhibitor, everolimus, at treating epilepsy in many individuals with tsc. None of this progress would have been possible without the critical support provided through the tscrp.global outreach works to address unmet needs within the global tsc community. The program provides the opportunity for the tsc alliance to share experiences and assist in the start-up of support of tsc-related organizations in other countries. A global alliance is a structured group of empowered and caring volunteers who work closely with the tsc alliance to facilitate local connections for individuals and families affected by tsc and raise revenue and awareness while supporting the mission of the organization. The tsc alliance has five global partnerships, including tsc alliance of israel, ts canada st, tsc alliance of mexico, hungarian foundation for tuberous sclerosis, and tsc alliance of india. The tsc alliance recognizes 14 tsc clinics in global alliance countries. Professional education expands programs to target researchers and healthcare providers caring for individuals with tsc, medical students, genetic counselors and educators to minimize the consequences of ignorance and misinformation. The tsc alliance exhibited at the american epilepsy society annual meeting. Staff members and a volunteer shared educational materials with attendees who visited the booth, and staff presented data at a poster session, attended scientific sessions, and held many meetings with academic and industry partners. Staff also participated in the tsc special interest group session, and the tsc alliance hosted more than 100 people at a reception which included a video presentation of how people's lives have been impacted by tsc, how research has made tremendous impact, and how much is left to be done to cure, or fully treat, tsc.the tsc alliance participated in or presented at 24 professional meetings in 2024 including research america annual advocacy awards, amgen future of ucds advisory board meeting, ats corporate advisory board meeting, boston children's hospital translational research symposium, ean congressional briefing, interagency collaborative to advance research in epilepsy (icare), health research alliance: convening on bullying and harassment forum, infantile spasms action network governance meeting, bridgebio town hall, tandem mini symposium, mnk advisory board meeting, ninds nonprofit forum, rare disease diversity coalition, tsci workshop, tand consortium, tsc reproductive & perinatal task force workshop, cpath global impact conference, global genes rare summit, boston children's hospital translational research symposium, pcori annual meeting, rdcrn fall meeting, aes, and the milken institute future of health summit.

Expenses: $392KGrants: $5K

Financials

FY 2024

Revenue

Contributions & grants$7.0M
Program service revenue$2.1M
Investment income$53K
Other revenue$795K
Total revenue$10.0M

Expenses

Grants paid$731K
Salaries & benefits$3.2M
Fundraising$1.3M
Other expenses$4.8M
Total expenses$8.7M
Total assets$17.3M
Net assets$15.4M

People

33 listed

NameRoleCompensation

KARI LUTHER ROSBECK

PRESIDENT & CEO

Board

$230K

54 hrs/wk

CYNTHIA ARCURI

CHIEF FINANCIAL OFFICER

Board

$184K

45 hrs/wk

JULIE BLUM

DIRECTOR

Board

2 hrs/wk

MATT BOLGER

DIRECTOR

Board

2 hrs/wk

CHIP BURKHALTER

DIRECTOR

Board

2 hrs/wk

LISA CARLTON

DIRECTOR

Board

2 hrs/wk

MARK CARROLL

DIRECTOR

Board

2 hrs/wk

JULIAN GANGOLLI

DIRECTOR

Board

2 hrs/wk

TANJALA GIPSON

DIRECTOR

Board

2 hrs/wk

JONATHAN GOLDSTEIN

DIRECTOR

Board

2 hrs/wk

STEVEN GOLDSTEIN

DIRECTOR

Board

2 hrs/wk

SHAFALI JESTE

DIRECTOR

Board

2 hrs/wk

WILLIAM JOSEPH

BOARD CHAIR

Board

5 hrs/wk

DARCY KRUEGER

DIRECTOR

Board

2 hrs/wk

PATROSKI LAWSON

DIRECTOR

Board

2 hrs/wk

KRISTI LENGYEL

DIRECTOR

Board

2 hrs/wk

HEATHER LENS

DIRECTOR

Board

2 hrs/wk

LAURA MARKS

DIRECTOR

Board

2 hrs/wk

MUSTAFA SAHIN

DIRECTOR

Board

2 hrs/wk

SEAN SHILLINGER

DIRECTOR

Board

2 hrs/wk

ANDREW SPERLING

DIRECTOR

Board

2 hrs/wk

MARK SPOTTS

DIRECTOR

Board

2 hrs/wk

VANESSA VAZQUEZ

DIRECTOR

Board

2 hrs/wk

JESSICA KREFTING

DIRECTOR

Board

2 hrs/wk

PAUL WAXLAX

VICE CHAIR

Board

5 hrs/wk

BRITTANY SMITH

TREASURER

Board

5 hrs/wk

LESLEY HOLMES

SECRETARY

Board

5 hrs/wk

DEREK BAUER

DIRECTOR

Board

2 hrs/wk

FRANCES BRIONES

DIRECTOR

Board

2 hrs/wk

STEVEN ROBERDS

CHIEF SCIENTIFIC OFFICER

Staff

$244K

45 hrs/wk

DEAN RAGER-AGUIAR

VICE PRESIDENT, TRANSLATIO

Staff

$183K

45 hrs/wk

JAYE ISHAM

CHIEF OUTREACH OFFICER

Staff

$154K

45 hrs/wk

LISA MOSS

VICE PRESIDENT, DONOR RELA

Staff

$129K

45 hrs/wk

Independent contractors

PSYCHOGENICS INC

RESEARCH LAB SERVICES

$2.2M

VAN ANDEL RESEARCH INSTITUTE

RESEARCH LAB SERVICES

$275K

CAVAROCCHI RUSCIO DENNIS & ASSOCIATES

GOVERNMENT RELATIONS

$122K

Grants received

Showing 119 of 119

FromAmountPurposeYear
$239K
PROGRAM SUPPORT
2024
$73K
MEDICAL / PUBLIC SERVICES
2024
$65K
DISEASE/DISORDER
2024
$50K
Health, Medicine & Science
2024
$50K
TO FURTHER THE ORGANIZATION'S EXEMPT PURPOSE
2024
$45K
UNRESTRICTED GENERAL SUPPORT
2024
$33K
GENERAL SUPPORT
2024
$26K
GENERAL SUPPORT
2024
$25K
Charitable Event
2024
$13K
Charitable Event
2024
$10K
Comedy For A Cure - Fund A Cure
2024
$5K
UNRESTRICTED GENERAL SUPPORT
2024
$5K
General & Unrestricted
2024
$2.3M
Anya's Accelerator Transforming TAND Translational Research
2023
$573K
PROGRAM SUPPORT
2023
$117K
For grant recipient's exempt purposes
2023
$75K
General Operating Support
2023
$69K
DISEASE/DISORDER
2023
$65K
HUMAN SERVICES
2023
$60K
MEDICAL / PUBLIC SERVICES
2023
$50K
TO FURTHER THE ORGANIZATION'S EXEMPT PURPOSE
2023
$30K
UNRESTRICTED GENERAL SUPPORT
2023
$28K
Charitable Event
2023
$17K
CHARITABLE DONATION
2023
$5K
Matching Gifts
2023
$5K
GENERAL SUPPORT
2023
$1K
Matching Gifts
2023
$1K
Matching Gifts
2023
$414
OTHER CIVIC / COMMUNITY
2023
$250
OTHER CIVIC / COMMUNITY
2023
$126
OTHER CIVIC / COMMUNITY
2023
$25
OTHER CIVIC / COMMUNITY
2023
$308K
PROGRAM SUPPORT
2022
$200K
Anya's Accelerator Transforming TAND Translational Research
2022
$100K
TO FURTHER THE ORGANIZATION'S EXEMPT PURPOSE
2022
$100K
GENERAL SUPPORT
2022
$75K
General Operating Support
2022
$50K
UNRESTRICTED GENERAL SUPPORT
2022
$45K
For grant recipient's exempt purposes
2022
$41K
2022 Infantile Spasms Awareness Network Governance Grant - $36,375; 2022 Infantile Spasms Awareness Week Grant - $5,000
2022
$31K
MEDICAL / PUBLIC SERVICES
2022
$23K
DISEASE/DISORDER
2022
$20K
GENERAL SUPPORT
2022
$14K
GENERAL SUPPORT
2022
$11K
GENERAL SUPPORT
2022
$5K
General & Unrestricted
2022
$3K
General & Unrestricted
2022
$518
MIP PAYOUT FOR 08/02/22
2022
$500
Matching Gifts
2022
$51
MIP PAYOUT FOR 05/04/2022
2022
$50
MIP PAYOUT FOR 06/03/2022
2022
$25
GENERAL OPERATING FUND
2022
$20
EMPLOYEE MATCHING GIFT DONATION
2022
$226K
PROGRAM SUPPORT
2021
$100K
PROGRAM SUPPORT
2021
$100K
TO FURTHER THE ORGANIZATION'S EXEMPT PURPOSE
2021
$54K
For grant recipient's exempt purposes
2021
$54K
For grant recipient's exempt purposes
2021
$32K
Infantile Spasms Awareness Week
2021
$13K
For recipient's exempt purpose
2021
$10K
GENERAL SUPPORT
2021
$8K
GENERAL OPERATING SUPPORT
2021
$7K
UNRESTRICTED
2021
$451
GENERAL OPERATING SUPPORT
2021
$331K
PROGRAM SUPPORT
2020
$167K
For grant recipient's exempt purposes
2020
$40K
MEDICAL / PUBLIC SERVICES
2020
$25K
TO FURTHER THE ORGANIZATION'S EXEMPT PURPOSE
2020
$10K
INFANTILE SPASMS AWARENESS WEEK GRANT
2020
$9K
Unrestricted
2020
$7K
FOR RECIPIENT'S EXEMPT PURPOSE
2020
$650
MATCHING GRANTS
2020
$500
Matching Gifts
2020
$99
GENERAL PURPOSE
2020
$25
GENERAL OPERATING PURPOSES
2020
$135K
For grant recipient's exempt purposes
2019
$52K
Participant Exchanges
2019
$25K
TO FURTHER THE ORGANIZATIONS EXEMPT PURPOSE
2019
$60K
Research
2018
$50K
PROGRAM SUPPORT
2018
$37K
Participant Exchanges
2018
$25K
TO FURTHER THE ORGANIZATIONS EXEMPT PURPOSE
2018
$13K
For grant recipient's exempt purposes
2018
$300
GENERAL OPERATING SUPPORT
2018
$120
Matching Grant
2018
$108K
FOR GRANT RECIPIENT'S EXEMPT PURPOSES
2017
$75K
Participant Exchanges
2017
$10K
Grants from Donor Advised Funds - Operating Support
2017

Funded by

$7.6M from 39 funders · 119 grants · 2017–2024

The Ramesh and Kalpana Bhatia Family

$2.6M · 8 grants · 2022–2024

Tsc Alliance Endowment Fund Inc

$1.7M · 6 grants · 2018–2024

Fidelity Investments Charitable Gift Fund

$695K · 8 grants · 2017–2023

Bny Mellon Charitable Gift Fund

$375K · 7 grants · 2018–2024

American Online Giving Foundation Inc

$259K · 6 grants · 2019–2024

The Ayco Charitable Foundation

$253K · 5 grants · 2019–2024

National Philanthropic Trust

$221K · 4 grants · 2019–2023

Donor Advised Charitable Giving Inc

$189K · 6 grants · 2018–2023

Details

EIN953018799
NTEE codeG030
Subsection03
Ruling date1975-10
Formed1975
Employees26
Volunteers373
NATIONAL TUBEROUS SCLEROSIS ASSOCIATION INC — Mission, Financials & Grants Received | Grantivo